Mouse Anti-Human SLC25A11 Monoclonal Antibody, Unconjugated, Clone 3G4 from Abnova Corporation

T4 Polynucleotide Kinase Exchange Reaction Buffer from Invitrogen

IMAGEQUANT 400 IQTL from GE Healthcare, formerly Amersham Biosciences

IMAGEQUANT 100 WKSTN from GE Healthcare, formerly Amersham Biosciences

FlowTACS Flow Cytometry Apoptosis Detection Kit from R&D Systems

T4 Polynucleotide Kinase Exchange Reaction Buffer from Invitrogen IMAGEQUANT 400 IQTL from GE Healthcare, formerly Amersham Biosciences IMAGEQUANT 100 WKSTN from GE Healthcare, formerly Amersham Biosciences FlowTACS Flow Cytometry Apoptosis Detection Kit from R&D Systems

(Date:11/25/2009)...e course of a lifetime, the heart pumps some 250 m...der to do this, the muscle fibers of the heart hav...ed by Dr. Wolfgang Rottbauer, vice chair of the De...Hospital (Chairman: Prof. Dr. H. A. Katus), has di...bility of the smallest muscular unit, the sarcomer...

(Date:11/24/2009)...us Research Institute (LRI) today named 12 new gra...million, recognize innovative work across a broad ...their creativity, novelty, and potential to drive ... and cure the complex disease of systemic lupus. ,...lupus researchers across the nation and include in...

(Date:11/24/2009)...mic-level action of a remarkable class of ring-sha...rs with the Lawrence Berkeley National Laboratory ...ystallography beamline at the Advanced Light Sourc...n gene expression and replication, and are vital t... infectious agents, such as the human papillomavir...

Breaking Biology News(10 mins):New genetic cause of cardiac failure discovered 2 Lupus Research Institute announces 2009 novel research grants 2 Lupus Research Institute announces 2009 novel research grants 3 Atomic-level snapshot catches protein motor in action 2 Atomic-level snapshot catches protein motor in action 3 Atomic-level snapshot catches protein motor in action 4 NIMBioS hosts tutorial on optimal control and optimization for biologists 10071 1 New Parkinsons Drug Draws Mixed Reviews 58192 1 New Parkinsons Drug Draws Mixed Reviews 58192 2 New Parkinsons Drug Draws Mixed Reviews 58192 3 Minorities Less Likely to Have Blood Pressure Under Control 58190 1 Minorities Less Likely to Have Blood Pressure Under Control 58190 2 Minorities Less Likely to Have Blood Pressure Under Control 58190 3

[1] New genetic cause of cardiac failure discovered [2] Lupus Research Institute announces 2009 novel research grants [1] Atomic-level snapshot catches protein motor in action

..., , Svilen Bobev, assistant professor of chemistry...ce Foundation,s prestigious Faculty Early Career D...g award, designed to support the integrated resear...their careers, is bestowed on those scientists and...ic leaders of the 21st century. Fewer than 20 perc...

..., Researchers from the University of North Caroli...mechanism that may account for the development of ...e born with in the US every year. The findings, p...oS Computational Biology, add new knowledge to und... also point the way to new corrective treatments. ...

..., NEW YORK (Feb. 28, 2007) -- The general public ...ase (CKD) is a serious and progressive medical con...ed. Understandably so, since in its early stages C...the disease and their health-care providers unawar...r, if CKD is detected and treated early, its wides...

Other Biology News:UD's Bobev receives NSF Early Career Award for research on novel compounds of rare Earth metals 2 UD's Bobev receives NSF Early Career Award for research on novel compounds of rare Earth metals 3 Computer simulations point to key molecular basis of cystic fibrosis 2 Simple screening questionnaire for kidney disease outperforms current clinical practice guidelines 2 Simple screening questionnaire for kidney disease outperforms current clinical practice guidelines 3 Simple screening questionnaire for kidney disease outperforms current clinical practice guidelines 4

UD's Bobev receives NSF Early Career Award for research on novel compounds of rare Earth metals Computer simulations point to key molecular basis of cystic fibrosis Simple screening questionnaire for kidney disease outperforms current clinical practice guidelines

(Date:11/24/2009)... , REYKJAVIK, Iceland, Novembe...c. (Nasdaq: DCGN ) today announced the approval of...ptcy Court for the District of Delaware,(the "Bank... petition for,relief under Chapter 11 of the Unite.... , The orders issued by the Bankruptcy C...

(Date:11/24/2009)... , SHANGHAI, Nov. 24 /PRNewswire-Asia/...ood & Drug Administration (SFDA) has approved ... its oral insulin project,(Nodlin), an innovative ...proval allows Biolaxy to initiate its first phase ...r characteristic of high blood glucose and poor,me...

(Date:11/24/2009)... , , Primary efficacy endpoint has been met... endometrial cancer, , QUEBEC CITY, Nov. 24 /...DAQ: AEZS ; TSX: AEZ) (the "Company"), a global b...apy and oncology, today announced positive efficac...toxic peptide conjugate, AEZS-108 (formerly AN-152...

(Date:11/24/2009)... , SAN DIEGO, Nov. 24, 2009 /PRNewswire-Fir...RNA ) announced today that the company is schedu...alth Care Conference on December 1, 2009 at 11:30 ...New York Palace Hotel in New York City. Jack Lief,... scheduled to provide an overview of the company, ...

Breaking Biology Technology:deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 2 deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 3 Biolaxy Secures IND Approval for Oral Insulin 2 AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2 AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3 AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4 Arena Pharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference 2 Arena Pharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference 3

[0] deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court [0] Biolaxy Secures IND Approval for Oral Insulin [0] AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer [0] Arena Pharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference

Products	Mouse Anti-Human SLC25A11 Monoclonal Antibody, Unconjugated, Clone 3G4 from Abnova Corporation
Company	Abnova Corporation
Item	Mouse Anti-Human SLC25A11 Monoclonal Antibody, Unconjugated, Clone 3G4
Price
Description	Mouse monoclonal antibody raised against a full length recombinant SLC25A11. NCBI Entrez Gene ID = SLC25A11
Info	Abnova Corporation Abnova Corporation (HQ) 9th Fl., No. 108, Jhouzih St. Neihu District, Taipei 114 Taiwan R.O.C. Tel: +886-2-8751-1888 Fax: +886-2-8751-1166 Abnova GmbH Boxbergring 107 69126 Heidelberg Germany Tel: +49 6221 3632226 Fax: +49 6221 825878 Customer Service: +886-2-8751-1888 Fax Number: +886-2-8751-1166 Web Site: http://www.abnova.com.tw